Akoya Biosciences, Inc. (Nasdaq: AKYA) – The Spatial Biology Company® – is thrilled to announce that it will be taking part in the 41st Annual J.P. Morgan Healthcare Conference. CEO Brian McKelligon will be presenting on Wednesday, January 11th, 2023 at 9:45 a.m. PT. Tune in to the live or archived webcast, available on Akoya’s website under the “Investors” tab, to catch all the action. Don’t miss out!
About Akoya Biosciences
Akoya Biosciences, The Spatial Biology Company®, is revolutionizing the way researchers explore the world of biology and human health. Through the power of spatial phenotyping, Akoya enables researchers to understand how cells organize and interact to influence disease and therapy response. Akoya provides a full suite of integrated, single-cell imaging solutions, including PhenoCycler™, PhenoImager™ Fusion and PhenoImager HT, to meet the needs of researchers in discovery, translational, and clinical research.